Libertyville, IL, United States of America

George A Doherty

This inventor holds 53 USPTO granted patents and 53 published patent applications, plus 7 CIPO patents and 18 EPO patents, primarily in Cancer Therapeutics (CPC class C07D). Top assignees: Abbvie Inc., Array Biopharma Inc., Merck + Co., Inc.. Active years: 2002-2024.

USPTO Granted Patents = 53 

% Patents Active = 64.2

 

 

Average Co-Inventor Count = 6.0

ph-index = 15

Forward Citations = 588(Granted Patents)

Forward Citations (Not Self Cited) = 471(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Princeton, NJ (US) (2002 - 2009)
  • Superior, CO (US) (2005 - 2014)
  • Boulder, CO (US) (2013 - 2016)
  • Libertyville, IL (US) (2011 - 2024)

Company Filing History:


Years Active: 2002-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Bcl-2 Inhibitors
NAMPT Inhibitors
Apoptosis Inducing Agents
Cancer Treatment
Toll-Like Receptor Modulators
Macrocyclic Inhibitors
Phenoxychroman Derivatives
Benzoazepines
Calcium Channel Blockers
Immune Diseases
Autoimmune Diseases
6-Substituted Derivatives
53 patents (USPTO):Explore Patents

Title: George A Doherty: Pioneering Innovations in Cancer Treatment

Introduction: George A Doherty, a prolific inventor based in Libertyville, IL, has marked his name in the field of medical advancements with an impressive portfolio of 52 patents. His groundbreaking work focuses on developing apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases.

Latest Patents: Among his recent patents is the development of compounds that target anti-apoptotic Bcl-2 and Bcl-xL proteins, offering promising avenues for combating diseases characterized by their overexpression. These inventions not only showcase his expertise but also signify a significant leap forward in the fight against such conditions.

Career Highlights: George A Doherty has contributed his innovative prowess to esteemed companies such as AbbVie Inc. and Array BioPharma Inc., where he played a pivotal role in driving research and development efforts aimed at revolutionizing healthcare solutions. His passion for creating impactful therapies has been evident throughout his career, inspiring many in the industry.

Collaborations: Throughout his journey, George A Doherty has collaborated with notable professionals in the field, including Zhi-Fu Tao and Andrew J Souers. Their shared dedication to advancing medical science has resulted in synergistic partnerships that have further propelled the innovative landscape within the healthcare sector.

Conclusion: In conclusion, George A Doherty's relentless pursuit of pioneering medical solutions stands as a testament to his unwavering commitment to making a difference in the world of healthcare. With his remarkable patents and collaborative spirit, he continues to shape the future of cancer treatment and disease management, leaving a lasting impact on the field of medical innovations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…